High-fat diet induces sarcopenic obesity in natural aging rats through the gut–trimethylamine N-oxide–muscle axis

• Published in: Journal of advanced research 2024-05
• Main Authors: Mo, Xiaoxing, Cheng, Ruijie, Shen, Lihui, Sun, Yunhong, Wang, Pei, Jiang, Guanhua, Wen, Lin, Li, Xiaoqin, Peng, Xiaobo, Liao, Yuxiao, He, Ruikun, Yan, Hong, Liu, Liegang
• Format: Article
• Language: English
• Subjects: Gut microbiota; High-fat diet; mTOR; Reactive oxygen species; Sarcopenic obesity; Trimethylamine N-oxide
• ISSN: 2090-1232; 2090-1224
• DOI: 10.1016/j.jare.2024.05.015

[Display omitted] •Long-term HFD induces sarcopenic obesity in natural aging rats.•HFD leads to the dysbiosis of gut microbiota and its metabolites and the impaired gut barrier.•TMAO, a typical microbial metabolite, is elevated in animal models of sarcopenic obesity.•A positive association is observed between the TMAO and sarcopenic obesity.•TMAO aggravates sarcopenic obesity via the ROS-AKT/mTOR signaling pathway. The lack of suitable animal models for sarcopenic obesity (SO) limits in-depth research into the disease. Emerging studies have demonstrated that gut dysbiosis is involved in the development of SO. As the importance of microbial metabolites is starting to unveil, it is necessary to comprehend the specific metabolites associated with gut microbiota and SO. We aimed to investigate whether high-fat diet (HFD) causes SO in natural aging animal models and specific microbial metabolites that are involved in linking HFD and SO. Young rats received HFD or control diet for 80 weeks, and obesity-related metabolic disorders and sarcopenia were measured. 16S rRNA sequencing and non-targeted and targeted metabolomics methods were used to detect fecal gut microbiota and serum metabolites. Gut barrier function was evaluated by intestinal barrier integrity and intestinal permeability. Trimethylamine N-oxide (TMAO) treatment was further conducted for verification. HFD resulted in body weight gain, dyslipidemia, impaired glucose tolerance, insulin resistance, and systemic inflammation in natural aging rats. HFD also caused decreases in muscle mass, strength, function, and fiber cross-sectional area and increase in muscle fatty infiltration in natural aging rats. 16S rRNA sequencing and nontargeted and targeted metabolomics analysis indicated that HFD contributed to gut dysbiosis, mainly characterized by increases in deleterious bacteria and TMAO. HFD destroyed intestinal barrier integrity and increased intestinal permeability, as evaluated by reducing levels of colonic mucin-2, tight junction proteins, goblet cells and elevating serum level of fluorescein isothiocyanate-dextran 4. Correlation analysis showed a positive association between TMAO and SO. In addition, TMAO treatment aggravated the development of SO in HFD-fed aged rats through regulating the ROS-AKT/mTOR signaling pathway. HFD leads to SO in natural aging rats, partially through the gut–microbiota–TMAO–muscle axis.